[{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"Apache License","title":"Apache License","text":"Version 2.0, January 2004 <http://www.apache.org/licenses/>","code":""},{"path":[]},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_1-definitions","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"1. Definitions","title":"Apache License","text":"“License” shall mean terms conditions use, reproduction, distribution defined Sections 1 9 document. “Licensor” shall mean copyright owner entity authorized copyright owner granting License. “Legal Entity” shall mean union acting entity entities control, controlled , common control entity. purposes definition, “control” means () power, direct indirect, cause direction management entity, whether contract otherwise, (ii) ownership fifty percent (50%) outstanding shares, (iii) beneficial ownership entity. “” (“”) shall mean individual Legal Entity exercising permissions granted License. “Source” form shall mean preferred form making modifications, including limited software source code, documentation source, configuration files. “Object” form shall mean form resulting mechanical transformation translation Source form, including limited compiled object code, generated documentation, conversions media types. “Work” shall mean work authorship, whether Source Object form, made available License, indicated copyright notice included attached work (example provided Appendix ). “Derivative Works” shall mean work, whether Source Object form, based (derived ) Work editorial revisions, annotations, elaborations, modifications represent, whole, original work authorship. purposes License, Derivative Works shall include works remain separable , merely link (bind name) interfaces , Work Derivative Works thereof. “Contribution” shall mean work authorship, including original version Work modifications additions Work Derivative Works thereof, intentionally submitted Licensor inclusion Work copyright owner individual Legal Entity authorized submit behalf copyright owner. purposes definition, “submitted” means form electronic, verbal, written communication sent Licensor representatives, including limited communication electronic mailing lists, source code control systems, issue tracking systems managed , behalf , Licensor purpose discussing improving Work, excluding communication conspicuously marked otherwise designated writing copyright owner “Contribution.” “Contributor” shall mean Licensor individual Legal Entity behalf Contribution received Licensor subsequently incorporated within Work.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_2-grant-of-copyright-license","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"2. Grant of Copyright License","title":"Apache License","text":"Subject terms conditions License, Contributor hereby grants perpetual, worldwide, non-exclusive, -charge, royalty-free, irrevocable copyright license reproduce, prepare Derivative Works , publicly display, publicly perform, sublicense, distribute Work Derivative Works Source Object form.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_3-grant-of-patent-license","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"3. Grant of Patent License","title":"Apache License","text":"Subject terms conditions License, Contributor hereby grants perpetual, worldwide, non-exclusive, -charge, royalty-free, irrevocable (except stated section) patent license make, made, use, offer sell, sell, import, otherwise transfer Work, license applies patent claims licensable Contributor necessarily infringed Contribution(s) alone combination Contribution(s) Work Contribution(s) submitted. institute patent litigation entity (including cross-claim counterclaim lawsuit) alleging Work Contribution incorporated within Work constitutes direct contributory patent infringement, patent licenses granted License Work shall terminate date litigation filed.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_4-redistribution","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"4. Redistribution","title":"Apache License","text":"may reproduce distribute copies Work Derivative Works thereof medium, without modifications, Source Object form, provided meet following conditions: () must give recipients Work Derivative Works copy License; (b) must cause modified files carry prominent notices stating changed files; (c) must retain, Source form Derivative Works distribute, copyright, patent, trademark, attribution notices Source form Work, excluding notices pertain part Derivative Works; (d) Work includes “NOTICE” text file part distribution, Derivative Works distribute must include readable copy attribution notices contained within NOTICE file, excluding notices pertain part Derivative Works, least one following places: within NOTICE text file distributed part Derivative Works; within Source form documentation, provided along Derivative Works; , within display generated Derivative Works, wherever third-party notices normally appear. contents NOTICE file informational purposes modify License. may add attribution notices within Derivative Works distribute, alongside addendum NOTICE text Work, provided additional attribution notices construed modifying License. may add copyright statement modifications may provide additional different license terms conditions use, reproduction, distribution modifications, Derivative Works whole, provided use, reproduction, distribution Work otherwise complies conditions stated License.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_5-submission-of-contributions","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"5. Submission of Contributions","title":"Apache License","text":"Unless explicitly state otherwise, Contribution intentionally submitted inclusion Work Licensor shall terms conditions License, without additional terms conditions. Notwithstanding , nothing herein shall supersede modify terms separate license agreement may executed Licensor regarding Contributions.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_6-trademarks","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"6. Trademarks","title":"Apache License","text":"License grant permission use trade names, trademarks, service marks, product names Licensor, except required reasonable customary use describing origin Work reproducing content NOTICE file.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_7-disclaimer-of-warranty","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"7. Disclaimer of Warranty","title":"Apache License","text":"Unless required applicable law agreed writing, Licensor provides Work (Contributor provides Contributions) “” BASIS, WITHOUT WARRANTIES CONDITIONS KIND, either express implied, including, without limitation, warranties conditions TITLE, NON-INFRINGEMENT, MERCHANTABILITY, FITNESS PARTICULAR PURPOSE. solely responsible determining appropriateness using redistributing Work assume risks associated exercise permissions License.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_8-limitation-of-liability","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"8. Limitation of Liability","title":"Apache License","text":"event legal theory, whether tort (including negligence), contract, otherwise, unless required applicable law (deliberate grossly negligent acts) agreed writing, shall Contributor liable damages, including direct, indirect, special, incidental, consequential damages character arising result License use inability use Work (including limited damages loss goodwill, work stoppage, computer failure malfunction, commercial damages losses), even Contributor advised possibility damages.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"id_9-accepting-warranty-or-additional-liability","dir":"","previous_headings":"Terms and Conditions for use, reproduction, and distribution","what":"9. Accepting Warranty or Additional Liability","title":"Apache License","text":"redistributing Work Derivative Works thereof, may choose offer, charge fee , acceptance support, warranty, indemnity, liability obligations /rights consistent License. However, accepting obligations, may act behalf sole responsibility, behalf Contributor, agree indemnify, defend, hold Contributor harmless liability incurred , claims asserted , Contributor reason accepting warranty additional liability. END TERMS CONDITIONS","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/LICENSE.html","id":"appendix-how-to-apply-the-apache-license-to-your-work","dir":"","previous_headings":"","what":"APPENDIX: How to apply the Apache License to your work","title":"Apache License","text":"apply Apache License work, attach following boilerplate notice, fields enclosed brackets [] replaced identifying information. (Don’t include brackets!) text enclosed appropriate comment syntax file format. also recommend file class name description purpose included “printed page” copyright notice easier identification within third-party archives.","code":"Copyright [yyyy] [name of copyright owner]  Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at    http://www.apache.org/licenses/LICENSE-2.0  Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License."},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/articles/omop.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Standardise OMOP results","text":"vignette illustrates EpiStandard can used standardise results IncidencePrevalence package, DARWIN-EU package estimating incidence prevalence data mapped OMOP Common Data Model.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/articles/omop.html","id":"set-up","dir":"Articles","previous_headings":"Introduction","what":"Set-up","title":"Standardise OMOP results","text":"first load relevant packages create mock OMOP-formatted dataset containing population outcome interest.","code":"library(EpiStandard) library(IncidencePrevalence) library(omopgenerics) library(dplyr)  cdm <- mockIncidencePrevalence(   sampleSize = 10000,   outPre = 0.25 )"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/articles/omop.html","id":"estimate-incidence-rates","dir":"Articles","previous_headings":"Introduction","what":"Estimate Incidence Rates","title":"Standardise OMOP results","text":"use IncidencePrevalence package generate denominator cohort age sex stratifications, calculate overall outcome incidence incidence calendar year stratum combination. information use package, refer website. Notice results stored summarised_result object. use EpiStandard, first filter incidence results age groups interest standardisation convert results format facilitates manipulation.","code":"cdm <- generateDenominatorCohortSet(   cdm = cdm,   name = \"denominator\",   cohortDateRange = as.Date(c(\"2008-01-01\", \"2020-01-01\")),   ageGroup = list(c(0, 19), c(20, 64), c(65, 150), c(0, 150)),   sex = c(\"Male\", \"Female\"),   daysPriorObservation = 0 )  inc <- estimateIncidence(   cdm = cdm,   denominatorTable = \"denominator\",   outcomeTable = \"outcome\",   interval = c(\"years\", \"overall\"),   outcomeWashout = 0,   repeatedEvents = FALSE )  inc |> glimpse() #> Rows: 1,049 #> Columns: 13 #> $ result_id        <int> 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,… #> $ cdm_name         <chr> \"mock\", \"mock\", \"mock\", \"mock\", \"mock\", \"mock\", \"mock… #> $ group_name       <chr> \"denominator_cohort_name &&& outcome_cohort_name\", \"d… #> $ group_level      <chr> \"denominator_cohort_8 &&& cohort_1\", \"denominator_coh… #> $ strata_name      <chr> \"overall\", \"overall\", \"overall\", \"overall\", \"overall\"… #> $ strata_level     <chr> \"overall\", \"overall\", \"overall\", \"overall\", \"overall\"… #> $ variable_name    <chr> \"Denominator\", \"Outcome\", \"Denominator\", \"Denominator… #> $ variable_level   <chr> NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, N… #> $ estimate_name    <chr> \"denominator_count\", \"outcome_count\", \"person_days\", … #> $ estimate_type    <chr> \"integer\", \"integer\", \"numeric\", \"numeric\", \"numeric\"… #> $ estimate_value   <chr> \"277\", \"14\", \"85765\", \"234.812\", \"5962.217\", \"3259.59… #> $ additional_name  <chr> \"incidence_start_date &&& incidence_end_date &&& anal… #> $ additional_level <chr> \"2008-01-01 &&& 2008-12-31 &&& years\", \"2008-01-01 &&…"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/articles/omop.html","id":"standardise-incidence-rates","dir":"Articles","previous_headings":"Introduction","what":"Standardise Incidence Rates","title":"Standardise OMOP results","text":"Now incidence results correct format, prepare reference population. example, use European Standard Population (esp2013). population uses 5-year age bands, merge groups match used estimate incidence. Finally, use dsr() function standardise incidence results reference population. specify columns containing event counts, person-years, population weights, well column identifying age groups. Since want standardise within outcome, sex, calendar-time stratum, use strata argument follows:","code":"incidenceTidy <- inc |>   filterSettings(denominator_age_group %in% c(\"0 to 19\", \"20 to 64\", \"65 to 150\")) |>   asIncidenceResult()  incidenceTidy |> glimpse() #> Rows: 69 #> Columns: 26 #> $ cdm_name                             <chr> \"mock\", \"mock\", \"mock\", \"mock\", \"… #> $ denominator_cohort_name              <chr> \"denominator_cohort_2\", \"denomina… #> $ outcome_cohort_name                  <chr> \"cohort_1\", \"cohort_1\", \"cohort_1… #> $ incidence_start_date                 <date> 2008-01-01, 2009-01-01, 2010-01-… #> $ incidence_end_date                   <date> 2008-12-31, 2009-12-31, 2010-12-… #> $ analysis_interval                    <chr> \"years\", \"years\", \"years\", \"years… #> $ analysis_censor_cohort_name          <chr> \"None\", \"None\", \"None\", \"None\", \"… #> $ analysis_complete_database_intervals <chr> \"TRUE\", \"TRUE\", \"TRUE\", \"TRUE\", \"… #> $ analysis_outcome_washout             <chr> \"0\", \"0\", \"0\", \"0\", \"0\", \"0\", \"0\"… #> $ analysis_repeated_events             <chr> \"FALSE\", \"FALSE\", \"FALSE\", \"FALSE… #> $ denominator_age_group                <chr> \"0 to 19\", \"0 to 19\", \"0 to 19\", … #> $ denominator_days_prior_observation   <chr> \"0\", \"0\", \"0\", \"0\", \"0\", \"0\", \"0\"… #> $ denominator_end_date                 <date> 2020-01-01, 2020-01-01, 2020-01-… #> $ denominator_requirements_at_entry    <chr> \"FALSE\", \"FALSE\", \"FALSE\", \"FALSE… #> $ denominator_sex                      <chr> \"Female\", \"Female\", \"Female\", \"Fe… #> $ denominator_start_date               <date> 2008-01-01, 2008-01-01, 2008-01-… #> $ denominator_target_cohort_name       <chr> \"None\", \"None\", \"None\", \"None\", \"… #> $ denominator_time_at_risk             <chr> \"0 to Inf\", \"0 to Inf\", \"0 to Inf… #> $ denominator_count                    <int> 38, 44, 38, 23, 16, 14, 8, 7, 4, … #> $ outcome_count                        <int> 0, 1, 1, 0, 1, 0, 0, 0, 0, 3, 3, … #> $ person_days                          <dbl> 12529, 12754, 10404, 7081, 5510, … #> $ person_years                         <dbl> 34.303, 34.919, 28.485, 19.387, 1… #> $ incidence_100000_pys                 <dbl> 0.000, 2863.770, 3510.620, 0.000,… #> $ incidence_100000_pys_95CI_lower      <dbl> 0.000, 72.504, 88.881, 0.000, 167… #> $ incidence_100000_pys_95CI_upper      <dbl> 10753.810, 15955.908, 19559.921, … #> $ result_type                          <chr> \"tidy_incidence\", \"tidy_incidence… standardPop <- mergeAgeGroups(   standardPopulation(\"esp2013\"),   newGroups = c(\"0 to 19\", \"20 to 64\", \"65 to 150\") ) |>   rename(\"denominator_age_group\" = \"age_group\") standardPop |> glimpse() #> Rows: 3 #> Columns: 2 #> $ denominator_age_group <chr> \"0 to 19\", \"20 to 64\", \"65 to 150\" #> $ pop                   <int> 21500, 59000, 19500 standardInc <- dsr(   data = incidenceTidy,   refdata = standardPop,   event = \"outcome_count\",   denominator = \"person_years\",   age = \"denominator_age_group\",   pop = \"pop\",   strata = c(\"incidence_start_date\", \"denominator_sex\", \"analysis_interval\", \"outcome_cohort_name\") ) standardInc |> glimpse() #> Rows: 26 #> Columns: 12 #> $ incidence_start_date    <date> 2008-01-01, 2009-01-01, 2010-01-01, 2011-01-0… #> $ denominator_sex         <chr> \"Female\", \"Female\", \"Female\", \"Female\", \"Femal… #> $ analysis_interval       <chr> \"years\", \"years\", \"years\", \"years\", \"years\", \"… #> $ outcome_cohort_name     <chr> \"cohort_1\", \"cohort_1\", \"cohort_1\", \"cohort_1\"… #> $ Numerator               <int> 14, 10, 14, 3, 4, 1, 1, 3, 1, 51, 13, 14, 9, 1… #> $ Denominator             <dbl> 234.813, 233.057, 209.706, 160.778, 132.954, 1… #> $ `Crude Rate (per 1000)` <dbl> 59.6219, 42.9080, 66.7601, 18.6593, 30.0856, 9… #> $ `95% LCL (Crude)`       <dbl> 28.3906, 16.3138, 31.7897, -2.4553, 0.6023, -9… #> $ `95% UCL (Crude)`       <dbl> 90.8532, 69.5021, 101.7306, 39.7738, 59.5689, … #> $ `Std Rate (per 1000)`   <dbl> 60.2832, 42.7653, 68.6842, 17.3819, 30.7820, 1… #> $ `95% LCL (Std)`         <dbl> 27.9721, 15.2756, 31.5812, -3.0871, -3.6202, -… #> $ `95% UCL (Std)`         <dbl> 92.5942, 70.2551, 105.7872, 37.8510, 65.1843, …"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Elin Rowlands. Author, maintainer. Marta Alcalde-Herraiz. Author. Nuria Mercade-Besora. Author. Edward Burn. Author. Danielle Newby. Author.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Rowlands E, Alcalde-Herraiz M, Mercade-Besora N, Burn E, Newby D (2026). EpiStandard: Package (One Line, Title Case). R package version 0.0.0.9000, https://oxford-pharmacoepi.github.io/EpiStandard/.","code":"@Manual{,   title = {EpiStandard: What the Package Does (One Line, Title Case)},   author = {Elin Rowlands and Marta Alcalde-Herraiz and Nuria Mercade-Besora and Edward Burn and Danielle Newby},   year = {2026},   note = {R package version 0.0.0.9000},   url = {https://oxford-pharmacoepi.github.io/EpiStandard/}, }"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/index.html","id":"epistandard-","dir":"","previous_headings":"","what":"What the Package Does (One Line, Title Case)","title":"What the Package Does (One Line, Title Case)","text":"goal EpiStandard provide functions allow age standardisation results produced epidemiological studies.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"What the Package Does (One Line, Title Case)","text":"can install development version EpiStandard GitHub :","code":"# install.packages(\"devtools\") devtools::install_github(\"oxford-pharmacoepi/EpiStandard\")"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/index.html","id":"main-functionalities","dir":"","previous_headings":"","what":"Main functionalities","title":"What the Package Does (One Line, Title Case)","text":"main functionality package calculate directly standardised rates.","code":"library(EpiStandard)"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/index.html","id":"example","dir":"","previous_headings":"Main functionalities","what":"Example","title":"What the Package Does (One Line, Title Case)","text":"","code":"df_study <- data.frame(state=rep(c('Miami',\"Alaska\"), c(5,5)),                        age=rep(c('0-14','15-24','25-44','45-64','65-150'),2),                        deaths=c(136,57,208,1016,3605,59,18,37,90,81),                        fu=c(114350,80259,133440,142670,92168,37164,20036,32693,14947,2077))   #US standard population  df_ref  <- data.frame(age=c('0-14','15-24','25-44','45-64','65-150'),                       pop=c(23961000,15420000,21353000,19601000,10685000))   #Directly standardised Rates (per 1000) - 95% CI's using the gamma method  my_results <- dsr(data = df_study,                    event = \"deaths\",                    denominator = \"fu\",                    strata = \"state\",                    age = \"age\",                    refdata = df_ref)    my_results |> dplyr::glimpse() ## Rows: 2 ## Columns: 9 ## $ state                   <chr> \"Miami\", \"Alaska\" ## $ Numerator               <dbl> 5022, 285 ## $ Denominator             <dbl> 562887, 106917 ## $ `Crude Rate (per 1000)` <dbl> 8.9219, 2.6656 ## $ `95% LCL (Crude)`       <dbl> 8.6751, 2.3561 ## $ `95% UCL (Crude)`       <dbl> 9.1686, 2.9751 ## $ `Std Rate (per 1000)`   <dbl> 6.9242, 6.7104 ## $ `95% LCL (Std)`         <dbl> 6.7304, 5.6667 ## $ `95% UCL (Std)`         <dbl> 7.1181, 7.7541"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/EpiStandard-package.html","id":null,"dir":"Reference","previous_headings":"","what":"EpiStandard: What the Package Does (One Line, Title Case) — EpiStandard-package","title":"EpiStandard: What the Package Does (One Line, Title Case) — EpiStandard-package","text":"package (one paragraph).","code":""},{"path":[]},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/EpiStandard-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"EpiStandard: What the Package Does (One Line, Title Case) — EpiStandard-package","text":"Maintainer: Elin Rowlands elin.rowlands@ndorms.ox.ac.uk (ORCID) Authors: Marta Alcalde-Herraiz marta.alcaldeherraiz@ndorms.ox.ac.uk (ORCID) Edward Burn edward.burn@ndorms.ox.ac.uk (ORCID) Danielle Newby danielle.newby@ndorms.ox.ac.uk (ORCID)","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/dsr.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate directly standardised rates — dsr","title":"Calculate directly standardised rates — dsr","text":"Computes crude directly standardised rates. Rates can stratified variables interest.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/dsr.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate directly standardised rates — dsr","text":"","code":"dsr(   data,   refdata = standardPopulation(\"esp2013\"),   event,   denominator,   age = \"age_group\",   pop = \"pop\",   strata = NULL,   multiplier = 1000,   method = \"normal\",   sig = 0.95 )"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/dsr.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate directly standardised rates — dsr","text":"data data frame event counts standardised. refdata data frame representing standard population. must contain two columns: age, different age groups (notice column name must data, defined input age); pop, number individuals corresponding age group. event Name column data corresponds event counts. denominator Name column data corresponds denominator population (person-time, e.g person-days, person-years etc). age Name column data refdata corresponds age groups. pop Name column refdata corresponds standard population age group. strata Name columns data rates calculated . multiplier constant multiply rates (e.g. multiplier = 1000 rates per 1000). method Choose normal, lognormal gamma confidence intervals crude standardised rates. default method normal. sig desired level confidence computing confidence intervals. default 0.95 95 percent CIs.","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/dsr.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Calculate directly standardised rates — dsr","text":"","code":"# An example of calculating directly standardised rates # Data example is from Table 1 (p.132) of Fundamentals of Epidemiology by Schoenbach, 2000.  # The following table shows the number of deaths, for 5 different age groups, # in the states of Miami and Alaska: data <- data.frame(       state = rep(c('Miami',\"Alaska\"), c(5,5)),       age_groups = rep(c('00-14','15-24','25-44','45-64','65+'),2),       deaths = c(136, 57, 208, 1016, 3605, 59, 18, 37, 90, 81),       general_population = c(114350,80259,133440,142670,92168,37164,20036,32693,14947,2077))  # We aim to standardise the number of deaths per each state. To do that, we will use the following # US standard population: standardised_population <- data.frame(                             age_groups = c('00-14','15-24','25-44','45-64','65+'),                             pop = c(23961000,15420000,21353000,19601000,10685000))  # Now we will use the function dsr to calculate the direct standardised rates # (per 1000 individuals) using a 95% CI calculated by the gamma method: my_results <- dsr(data = data,                   refdata = standardised_population,                   event = \"deaths\",                   denominator  = \"general_population\",                   age   = \"age_groups\",                   pop   = \"pop\",                   strata = \"state\",                   multiplier = 1000,                   method = \"gamma\",                   sig = 0.95) # View results my_results #> # A tibble: 2 × 9 #>   state  Numerator Denominator `Crude Rate (per 1000)` `95% LCL (Crude)` #>   <chr>      <dbl>       <dbl>                   <dbl>             <dbl> #> 1 Miami       5022      562887                    8.92              8.68 #> 2 Alaska       285      106917                    2.67              2.37 #> # ℹ 4 more variables: `95% UCL (Crude)` <dbl>, `Std Rate (per 1000)` <dbl>, #> #   `95% LCL (Std)` <dbl>, `95% UCL (Std)` <dbl>"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/esp2013.html","id":null,"dir":"Reference","previous_headings":"","what":"ESP13 — esp2013","title":"ESP13 — esp2013","text":"ESP13","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/esp2013.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"ESP13 — esp2013","text":"","code":"esp2013"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/esp2013.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"ESP13 — esp2013","text":"data frame","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/espSex2013.html","id":null,"dir":"Reference","previous_headings":"","what":"ESP13 by Sex — espSex2013","title":"ESP13 by Sex — espSex2013","text":"ESP13 Sex","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/espSex2013.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"ESP13 by Sex — espSex2013","text":"","code":"espSex2013"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/espSex2013.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"ESP13 by Sex — espSex2013","text":"data frame","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/mergeAgeGroups.html","id":null,"dir":"Reference","previous_headings":"","what":"Create new merged age groups — mergeAgeGroups","title":"Create new merged age groups — mergeAgeGroups","text":"Create new merged age groups","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/mergeAgeGroups.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create new merged age groups — mergeAgeGroups","text":"","code":"mergeAgeGroups(   refdata,   newGroups,   event = NULL,   age = \"age_group\",   pop = \"pop\",   strata = NULL )"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/mergeAgeGroups.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create new merged age groups — mergeAgeGroups","text":"refdata Standard population dataset want use. newGroups Create list new age groups want create. event Column refdata outcome counts. age Column refdata age values. pop Column refdata population counts, preferably person-time. strata Column columns stratify .","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/mergeAgeGroups.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create new merged age groups — mergeAgeGroups","text":"Table","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/mergeAgeGroups.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create new merged age groups — mergeAgeGroups","text":"","code":"# \\donttest{   esp2013|> dplyr::glimpse() #> Rows: 19 #> Columns: 2 #> $ age_group <chr> \"0 to 4\", \"5 to 9\", \"10 to 14\", \"15 to 19\", \"20 to 24\", \"25 … #> $ pop       <int> 5000, 5500, 5500, 5500, 6000, 6000, 6500, 7000, 7000, 7000, …  merged_data <- mergeAgeGroups(standardPopulation(\"esp2013\"), c(\"0-19\", \"20-64\", \"65-150\"))  merged_data |> dplyr::glimpse() #> Rows: 3 #> Columns: 2 #> $ age_group <chr> \"0-19\", \"20-64\", \"65-150\" #> $ pop       <int> 21500, 59000, 19500  # }"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/standardPopulation.html","id":null,"dir":"Reference","previous_headings":"","what":"Standard population — standardPopulation","title":"Standard population — standardPopulation","text":"Standard population","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/standardPopulation.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Standard population — standardPopulation","text":"","code":"standardPopulation(name = \"esp2013\")"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/standardPopulation.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Standard population — standardPopulation","text":"name Dataset use. One \"esp2013\", \"espSex2013\", \"wsp2025\" \"wspSex2025\".","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/standardPopulation.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Standard population — standardPopulation","text":"Tibble","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/standardPopulation.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Standard population — standardPopulation","text":"","code":"# \\donttest{ standard_data <- standardPopulation(\"esp2013\") # }"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wsp2025.html","id":null,"dir":"Reference","previous_headings":"","what":"WSP — wsp2025","title":"WSP — wsp2025","text":"WSP","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wsp2025.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"WSP — wsp2025","text":"","code":"wsp2025"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wsp2025.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"WSP — wsp2025","text":"data frame","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wspSex2025.html","id":null,"dir":"Reference","previous_headings":"","what":"WSP by Sex — wspSex2025","title":"WSP by Sex — wspSex2025","text":"WSP Sex","code":""},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wspSex2025.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"WSP by Sex — wspSex2025","text":"","code":"wspSex2025"},{"path":"https://github.com/oxford-pharmacoepi/EpiStandard/reference/wspSex2025.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"WSP by Sex — wspSex2025","text":"data frame","code":""}]
